Skip header and navigation

Refine By

192 records – page 1 of 20.

[Actual nutrition and vitamin status of school children in the Orla region].

https://arctichealth.org/en/permalink/ahliterature193539
Source
Gig Sanit. 2001 May-Jun;(3):54-7
Publication Type
Article
Author
G G Ladnova
A V Istomin
A V Nikolaev
Source
Gig Sanit. 2001 May-Jun;(3):54-7
Language
Russian
Publication Type
Article
Keywords
Adolescent
Adolescent Nutritional Physiological Phenomena
Age Factors
Ascorbic Acid - administration & dosage
Female
Humans
Male
Rural Population
Russia
Sex Factors
Urban Population
Vitamin A - administration & dosage
Vitamin B Complex - administration & dosage
Vitamins - administration & dosage
Abstract
The actual nutrition and vitamin provision in 14-17-year-old schoolchildren in Oryol and the Oryol Region were studied within the framework of the working programme. Sanitary recommendations for vitamin prophylaxis were developed. Evidence is provided for the biomedical efficiency of vitamin prophylaxis.
PubMed ID
11519465 View in PubMed
Less detail

Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease.

https://arctichealth.org/en/permalink/ahliterature161617
Source
J Am Diet Assoc. 2007 Sep;107(9):1575-80
Publication Type
Article
Date
Sep-2007
Author
Elaheh Aghdassi
Barbara E Wendland
Melanie Stapleton
Maitreyi Raman
Johane P Allard
Author Affiliation
The University Health Network, Toronto, Canada.
Source
J Am Diet Assoc. 2007 Sep;107(9):1575-80
Date
Sep-2007
Language
English
Publication Type
Article
Keywords
Adult
Body mass index
Canada
Crohn Disease - diet therapy - physiopathology
Cross-Sectional Studies
Diet - standards
Diet Records
Dietary Supplements
Energy intake
Female
Humans
Male
Minerals - administration & dosage
Nutrition Policy
Nutritional Physiological Phenomena
Nutritional Requirements
Nutritional Status
Severity of Illness Index
Vitamins - administration & dosage
Abstract
Crohn's disease is frequently associated with nutritional deficiencies, often a result of disease activity and poor oral intake. This study investigated the adequacy of dietary intake, based on the Canadian Dietary Reference Intake, in ambulatory patients with Crohn's disease and a normal body mass index (BMI; calculated as kg/m(2)). This was a cross-sectional study of 74 patients with mean age of 35.7+/-1.4 years and BMI of 23.05+/-0.45. All patients completed a 7-day food record and a diary for the Crohn's Disease Activity Index. Mean Crohn's Disease Activity Index was 138.99+/-11.38. Energy and protein intakes were within the recommended levels of intake, but total carbohydrates, fat, and saturated fat intake exceeded the recommended levels of
PubMed ID
17761234 View in PubMed
Less detail

The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial.

https://arctichealth.org/en/permalink/ahliterature276361
Source
Nutr Cancer. 2015;67(8):1355-8
Publication Type
Article
Date
2015
Author
Geir Bjørklund
Source
Nutr Cancer. 2015;67(8):1355-8
Date
2015
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Ascorbic Acid - administration & dosage
Breast Neoplasms - mortality - pathology - therapy
Chemotherapy, Adjuvant
Clinical Trials as Topic
Denmark
Fatty Acids, Essential - administration & dosage
Female
Humans
Lymphatic Metastasis
Middle Aged
Nutrition Therapy
Selenium - administration & dosage
Survival Rate
Trace Elements - administration & dosage
Ubiquinone - administration & dosage - analogs & derivatives
Vitamin E - administration & dosage
Vitamins - administration & dosage
beta Carotene - administration & dosage
Abstract
Adjuvant Nutritional Intervention in Cancer (ANICA) was a clinical study carried out in Denmark in the 1990s with 32 typical patients with breast cancer, aged 32-81 yr and classified high risk because of tumor spread to the lymph nodes. The patients received standard therapy for their breast cancer, but got from the start additionally an adjuvant therapy in form of a cocktail consisting of vitamin C (2,850 mg/day), vitamin E (2,500 IU/day), beta-carotene (32.5 IU/day), selenium (Se; 387 micrograms/day), various other vitamins and essential trace elements, essential fatty acids (1.2 g gamma-linolenic acid/day and 3.5 g omega-3 PUFAs/day), and coenzyme Q10 (CoQ10, 90 mg/day). The protocol was later changed, with reduction of the Se intake and more coenzyme Q10 than when the study was started. The average survival of high-risk breast patients in the study was 50% after 5 yr, whereas for low-risk breast cancer patients (without metastases in the axilla when treatment was started), the average survival was 90% after ten years. The main investigator died, and the final report from the ANICA study was therefore never written. However, the published preliminary results from the trial were very promising; it seems, therefore, important to follow-up this study.
PubMed ID
26473998 View in PubMed
Less detail

Advances in pharmacological strategies for the prevention of cataract development.

https://arctichealth.org/en/permalink/ahliterature151401
Source
Indian J Ophthalmol. 2009 May-Jun;57(3):175-83
Publication Type
Article
Author
S K Gupta
V Kalai Selvan
S S Agrawal
Rohit Saxena
Author Affiliation
Delhi Institute of Pharmaceutical Sciences and Research, Sector 3, Pushp Vihar, New Delhi-110 017, India. skgup@hotmail.com
Source
Indian J Ophthalmol. 2009 May-Jun;57(3):175-83
Language
English
Publication Type
Article
Keywords
Aldehyde Reductase - antagonists & inhibitors
Antioxidants - administration & dosage
Cataract - etiology - prevention & control
Glutathione - administration & dosage
Humans
Pharmaceutical Preparations
Risk factors
Vitamins - administration & dosage
Abstract
Cataractous-opacification of the lens is one of the leading causes of blindness in India. The situation can be managed by surgical removal of the cataractous lens. Various pharmacological strategies have been proposed for the prevention and treatment of cataract. Information on possible benefits of putative anticataract agents comes from a variety of approaches, ranging from laboratory experiments, both in vitro and in vivo , to epidemiological studies in patients. This review deals with the various mechanisms, and possible pharmacological interventions for the prevention of cataract. The article also reviews research on potential anticataractous agents, including aldose reductase inhibitors, glutathione boosters, antiglycating agents, vitamins and various drugs from indigenous sources.
Notes
Cites: J Diabetes Complications. 2004 Mar-Apr;18(2):129-4015120709
Cites: Drugs R D. 2004;5(3):125-3915139774
Cites: J Ethnopharmacol. 2004 Aug;93(2-3):289-9415234767
Cites: Indian J Exp Biol. 2004 Jun;42(6):601-315260112
Cites: Jpn J Ophthalmol. 2004 Sep-Oct;48(5):499-50215486777
Cites: Indian J Exp Biol. 1969 Jan;7(1):25-65771164
Cites: Science. 1975 Jun 20;188(4194):1215-61145193
Cites: Acta Ophthalmol (Copenh). 1979;57(6):1107-16232607
Cites: Lancet. 1981 Feb 7;1(8215):338-96109987
Cites: Lancet. 1982 Apr 10;1(8276):849-506122073
Cites: Fortschr Ophthalmol. 1982 Nov;79(3):179-836764443
Cites: Ciba Found Symp. 1984;106:65-876568981
Cites: Metabolism. 1985 Apr;34(4):336-443920474
Cites: Arch Biochem Biophys. 1985 Jun;239(2):491-62988452
Cites: Exp Eye Res. 1986 Feb;42(2):167-753699106
Cites: Ital J Biochem. 1987 May-Jun;36(3):153-653610598
Cites: Curr Eye Res. 1987 Oct;6(10):1249-563677785
Cites: Vet Ophthalmol. 2006 Sep-Oct;9(5):292-816939456
Cites: Phytother Res. 2006 Dec;20(12):1091-517009203
Cites: Free Radic Biol Med. 2007 Apr 1;42(7):1098-10517349936
Cites: J Ocul Pharmacol Ther. 2007 Apr;23(2):188-9517444807
Cites: J Med Food. 2007 Jun;10(2):308-1517651067
Cites: Mol Vis. 2007;13:1291-717679931
Cites: Life Sci. 1999;65(18-19):1995-710576453
Cites: Am J Ophthalmol. 1999 Oct;128(4):446-6510577586
Cites: Curr Eye Res. 1995 Aug;14(8):643-98529399
Cites: Acta Ophthalmol Scand. 1995 Aug;73(4):329-328646578
Cites: Biochem Mol Biol Int. 1995 May;35(6):1281-977492966
Cites: Glycoconj J. 1995 Oct;12(5):618-218595250
Cites: Exp Eye Res. 1996 Jan;62(1):11-98674506
Cites: Pharmacol Res. 1995 Dec;32(6):369-738736488
Cites: Adv Pharmacol. 1997;38:3-208895801
Cites: Br J Ophthalmol. 1996 Sep;80(9):840-38942384
Cites: Arch Toxicol. 1997;71(5):283-99137806
Cites: Exp Eye Res. 1997 Oct;65(4):507-169464184
Cites: Nutr Rev. 1998 Feb;56(2 Pt 1):35-519529899
Cites: Gen Pharmacol. 1998 May;30(5):627-389559311
Cites: Indian J Ophthalmol. 1997 Dec;45(4):221-59567017
Cites: Ophthalmic Res. 2004 Sep-Oct;36(5):264-915583432
Cites: Exp Eye Res. 2004 Dec;79(6):913-815642329
Cites: Mol Vis. 2005 Jan 19;11:56-6515682043
Cites: J Ethnopharmacol. 2005 Feb 28;97(2):397-40315707781
Cites: Mol Cell Biochem. 2005 Jan;269(1-2):115-2015786723
Cites: J Agric Food Chem. 2005 May 4;53(9):3710-315853424
Cites: Exp Eye Res. 2005 May;80(5):709-2515862178
Cites: Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2092-915914628
Cites: Biol Pharm Bull. 2005 Jun;28(6):1103-515930755
Cites: Am J Epidemiol. 2005 Jul 1;162(1):73-915961589
Cites: Curr Eye Res. 2005 Jul;30(7):583-9116020293
Cites: Ophthalmic Res. 2005 May-Jun;37(3):142-915867476
Cites: J Cataract Refract Surg. 2006 Jun;32(6):1041-516814068
Cites: Ophthalmology. 2000 Mar;107(3):450-610711880
Cites: Am J Physiol Regul Integr Comp Physiol. 2000 Mar;278(3):R572-710712274
Cites: J Ocul Pharmacol Ther. 2000 Apr;16(2):193-20110803430
Cites: Diabetes Obes Metab. 2000 Jun;2(3):165-7411220552
Cites: Altern Med Rev. 2001 Apr;6(2):141-6611302779
Cites: Int J Vitam Nutr Res. 2001 Mar;71(2):103-911339106
Cites: Clin Chem Lab Med. 2001 Feb;39(2):143-511341748
Cites: Curr Eye Res. 2001 Mar;22(3):215-2011462158
Cites: Exp Eye Res. 2001 Sep;73(3):393-40111520114
Cites: Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1116-2011923254
Cites: Am J Epidemiol. 2002 Jun 1;155(11):997-100612034578
Cites: Ophthalmic Res. 2002 Jul-Aug;34(4):258-6312297700
Cites: Br J Nutr. 2002 Oct;88(4):347-5412323084
Cites: Mol Vis. 2003 Jun 9;9:223-3012802258
Cites: Nutrition. 2003 Sep;19(9):794-912921892
Cites: Mol Vis. 2004 Mar 12;10:148-5415031705
Cites: Dev Ophthalmol. 1987;15:82-913691928
Cites: Exp Eye Res. 1988 Aug;47(2):217-253409993
Cites: J Ocul Pharmacol. 1988 Fall;4(3):243-513198985
Cites: Acta Ophthalmol (Copenh). 1989 Oct;67(5):518-242589050
Cites: Clin Pharm. 1990 Jun;9(6):446-572114249
Cites: Dev Ophthalmol. 1991;21:151-61907930
Cites: Dev Ophthalmol. 1991;21:170-81907931
Cites: J Biol Chem. 1992 May 25;267(15):10211-41587810
Cites: Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2511-91321798
Cites: Drugs Aging. 1992 Jul-Aug;2(4):287-3001504443
Cites: Diabetes. 1992 Oct;41 Suppl 2:36-411526333
Cites: Exp Eye Res. 1994 Feb;58(2):207-188157113
Cites: J Am Coll Nutr. 1994 Aug;13(4):344-507963139
Cites: Ophthalmic Res. 1994;26(4):226-317808733
Cites: Am J Epidemiol. 1995 Feb 15;141(4):322-347840110
Cites: J Pineal Res. 1994 Sep;17(2):94-1007869232
Cites: Br J Ophthalmol. 1995 Mar;79(3):202-67703194
Cites: Free Radic Biol Med. 1995 Apr;18(4):823-97750805
Cites: Annu Rev Med. 1995;46:223-347598459
Cites: Exp Eye Res. 1995 May;60(5):483-937615014
Cites: FASEB J. 1995 Sep;9(12):1173-827672510
PubMed ID
19384010 View in PubMed
Less detail

[A hygienic appraisal of the actual nutrition and nutritional status of boarding school pupils in the Komi Republic].

https://arctichealth.org/en/permalink/ahliterature211957
Source
Gig Sanit. 1996 May-Jun;(3):20-2
Publication Type
Article
Author
A V Istomin
I G Mikhailov
A L Kozlova
Source
Gig Sanit. 1996 May-Jun;(3):20-2
Language
Russian
Publication Type
Article
Keywords
Child
Child Nutritional Physiological Phenomena
Diet
Energy intake
Energy Metabolism
Humans
Nutritional Status
Russia
Seasons
Vitamins - administration & dosage
Abstract
Energy expenditure, physical and mental capacity for work, ascorbic acid excretion, basic foodstuff supply were investigated in 7-9-year-old pupils from boarding schools. Specific features of the alimentary state of the children were used as a basis for working out hygienic recommendations to improve children's diets and health.
PubMed ID
8925956 View in PubMed
Less detail

[Alimentary risk factors of osteoporosis].

https://arctichealth.org/en/permalink/ahliterature151672
Source
Vopr Pitan. 2009;78(1):22-32
Publication Type
Article
Date
2009
Author
V M Kodentsova
O A Vrzhesinskaia
A A Svetikova
B S Kaganov
Source
Vopr Pitan. 2009;78(1):22-32
Date
2009
Language
Russian
Publication Type
Article
Keywords
Age Factors
Bone Density - genetics - physiology
Calcium - administration & dosage
Cardiovascular Diseases - complications
Food - standards
Gastrointestinal Diseases - complications
Humans
Malnutrition - complications
Motor Activity - physiology
Osteoporosis - etiology - genetics - metabolism
Risk factors
Russia
Vitamins - administration & dosage
Abstract
The data on of alimentary risk factors of osteoporosis have been observed. The frequency of decreased bone mineral density, vitamin and calcium diet content and sufficiency with vitamins evaluated by means of blood serum level determination among patients suffering from chronic diseases (of cardiovascular system, gastrointestinal tract, osteopenia and osteoporosis).
PubMed ID
19348280 View in PubMed
Less detail

Antioxidant vitamin intake and mortality in three Central and Eastern European urban populations: the HAPIEE study.

https://arctichealth.org/en/permalink/ahliterature278739
Source
Eur J Nutr. 2016 Mar;55(2):547-60
Publication Type
Article
Date
Mar-2016
Author
Urszula Stepaniak
Agnieszka Micek
Giuseppe Grosso
Denes Stefler
Roman Topor-Madry
Ruzena Kubinova
Sofia Malyutina
Anne Peasey
Hynek Pikhart
Yuri Nikitin
Martin Bobak
Andrzej Pajak
Source
Eur J Nutr. 2016 Mar;55(2):547-60
Date
Mar-2016
Language
English
Publication Type
Article
Keywords
Aged
Antioxidants - administration & dosage
Ascorbic Acid - administration & dosage
Cardiovascular Diseases - mortality
Cause of Death
Czech Republic - epidemiology
Dietary Supplements
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms - mortality
Poland - epidemiology
Proportional Hazards Models
Prospective Studies
Risk factors
Russia - epidemiology
Socioeconomic Factors
Surveys and Questionnaires
Urban Population
Vitamin E - administration & dosage
Vitamins - administration & dosage
beta Carotene - administration & dosage
Abstract
The aim of the study was to assess the relationships between individual-level dietary intakes of antioxidant vitamins C, E and beta-carotene with all-cause and cause-specific mortality in three Central and Eastern European (CEE) populations.
Data from the Health, Alcohol and Psychosocial factors in Eastern Europe cohort study were used. At the baseline survey, between 2002 and 2005, 28,945 men and women aged 45-69 years were examined in Novosibirsk (Russia), Krakow (Poland) and seven Czech towns. Deaths in the cohorts were identified through mortality registers. Cox regression was used to estimate the association between vitamin consumption and all-cause, cardiovascular (CVD) disease and cancer mortality.
In multivariable-adjusted analyses, there were no clear inverse associations between antioxidant vitamin intakes and mortality, although in some groups, several hazard ratios (HRs) were significant. For example, in men, compared with the lowest quintile of vitamin C intake, all-cause mortality in the third and fourth quintiles was lower by 28 % (HR 0.72; 95 % CI 0.61-0.85) and by 20 % (HR 0.80; 95 % CI 0.68-0.95), respectively. CVD mortality was lower by 35 % (HR 0.65; 95 % CI 0.50-0.84) and by 23 % (HR 0.77; 95 % CI 0.59-0.99) in third and fourth quintile of vitamin C intake, respectively. In women, the third and fourth quintiles of dietary intake of vitamin E were associated with reduced risk of all-cause death by 33 % (HR 0.67; 95 % CI 0.53-0.84) and by 23 % (HR 0.77; 95 % CI 0.61-0.97), respectively. Consumption of vitamin C, vitamin E and beta-carotene was not related to CVD mortality in women and to cancer mortality in either gender.
This large prospective cohort study in CEE populations with low prevalence of vitamin supplementation did not find a strong, dose-response evidence for protective effects of antioxidant vitamin intake.
Notes
Cites: Int J Epidemiol. 2000 Apr;29(2):260-510817122
Cites: Public Health Nutr. 2014 Oct;17(10):2278-8623987990
Cites: Nutrition. 2000 Sep;16(9):785-610978865
Cites: J Nutr. 2002 Apr;132(4):756-6111925473
Cites: J Intern Med. 2002 May;251(5):372-9211982737
Cites: Proc Nutr Soc. 2002 Aug;61(3):397-40012230799
Cites: J Am Coll Nutr. 2003 Feb;22(1):18-3512569111
Cites: Am J Clin Nutr. 2003 Jun;77(6):1390-912791615
Cites: Am J Clin Nutr. 2003 Nov;78(5):999-101014594788
Cites: Lancet. 2004 May 22;363(9422):1724-715158637
Cites: N Engl J Med. 1993 May 20;328(20):1444-98479463
Cites: J Natl Cancer Inst. 1994 Sep 21;86(18):1390-78072032
Cites: Am J Epidemiol. 1995 Dec 15;142(12):1269-787503047
Cites: Radiat Res. 1996 May;145(5):532-418619018
Cites: Am J Epidemiol. 1996 Sep 1;144(5):501-118781466
Cites: Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S9094926
Cites: Am J Epidemiol. 2004 Dec 15;160(12):1223-3315583375
Cites: Am J Clin Nutr. 2004 Dec;80(6):1508-2015585762
Cites: Free Radic Res. 2005 Jul;39(7):671-8616036346
Cites: BMC Public Health. 2006;6:25517049075
Cites: Am J Clin Nutr. 2007 Jun;85(6):1634-4217556703
Cites: Eur J Epidemiol. 2008;23(1):3-1017955332
Cites: J Nutr. 2008 Feb;138(2):344-5018203902
Cites: Eur J Nutr. 2008 May;47 Suppl 2:3-1818458831
Cites: BMC Public Health. 2009;9:43919951409
Cites: Rocz Panstw Zakl Hig. 2009;60(3):275-820063699
Cites: Br J Nutr. 2009 Dec;102 Suppl 1:S10-3720100364
Cites: Int J Cancer. 2011 Mar 1;128(5):1169-7820473915
Cites: Br J Nutr. 2011 Jan;105(1):123-3220807458
Cites: Stroke. 2011 Jun;42(6):1665-7221512181
Cites: Curr Aging Sci. 2011 Jul;4(2):158-7021235492
Cites: Free Radic Biol Med. 2011 Sep 1;51(5):1000-1321664268
Cites: Ann Agric Environ Med. 2012;19(2):181-9222742786
Cites: Eur J Nutr. 2012 Sep;51(6):637-6322684631
Cites: Public Health Nutr. 2013 May;16(5):824-4022995736
Cites: Crit Rev Food Sci Nutr. 2013;53(7):706-2123638931
Cites: Front Biosci (Landmark Ed). 2013;18:1017-2923747864
Cites: PLoS One. 2013;8(6):e6585623762441
Cites: PLoS One. 2013;8(9):e7455824040282
Cites: J Epidemiol Community Health. 2014 Apr;68(4):297-30324227051
Cites: Biomed Res Int. 2014;2014:83184124804252
Cites: Eur J Clin Nutr. 2014 Dec;68(12):1346-5225028084
Cites: Am J Clin Nutr. 2000 Aug;72(2):476-8310919944
PubMed ID
25762013 View in PubMed
Less detail

Anti-oxidant vitamin status of Russian children and elderly.

https://arctichealth.org/en/permalink/ahliterature212556
Source
Eur J Clin Nutr. 1996 Mar;50(3):195-6
Publication Type
Article
Date
Mar-1996

Ascorbic acid supplements and kidney stone incidence among men: a prospective study.

https://arctichealth.org/en/permalink/ahliterature116587
Source
JAMA Intern Med. 2013 Mar 11;173(5):386-8
Publication Type
Article
Date
Mar-11-2013
Author
Laura D K Thomas
Carl-Gustaf Elinder
Hans-Göran Tiselius
Alicja Wolk
Agneta Akesson
Source
JAMA Intern Med. 2013 Mar 11;173(5):386-8
Date
Mar-11-2013
Language
English
Publication Type
Article
Keywords
Aged
Ascorbic Acid - administration & dosage - adverse effects - pharmacokinetics
Calcium Oxalate - metabolism
Cohort Studies
Dietary Supplements - adverse effects
Dose-Response Relationship, Drug
Humans
Incidence
Kidney Calculi - chemically induced - epidemiology - metabolism
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Risk assessment
Sweden
Vitamins - administration & dosage - adverse effects - pharmacokinetics
Notes
Comment In: JAMA Intern Med. 2013 Jul 22;173(14):138423877084
Comment In: JAMA Intern Med. 2013 Jul 22;173(14):138423877085
Comment In: Nat Rev Urol. 2013 Apr;10(4):18423419496
Comment In: JAMA Intern Med. 2013 Mar 11;173(5):375-9423381657
Comment In: J Urol. 2013 Oct;190(4):1268-924029326
Comment In: Nat Rev Nephrol. 2013 Apr;9(4):18723419349
PubMed ID
23381591 View in PubMed
Less detail

Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort.

https://arctichealth.org/en/permalink/ahliterature89309
Source
Am J Epidemiol. 2009 Jun 1;169(11):1304-11
Publication Type
Article
Date
Jun-1-2009
Author
Catov Janet M
Nohr Ellen A
Bodnar Lisa M
Knudson Vibeke K
Olsen Sjurdur F
Olsen Jorn
Author Affiliation
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. catovjm@upmc.edu
Source
Am J Epidemiol. 2009 Jun 1;169(11):1304-11
Date
Jun-1-2009
Language
English
Publication Type
Article
Keywords
Adult
Body mass index
Body Weight
Confounding Factors (Epidemiology)
Denmark
Female
Folic Acid - administration & dosage
Humans
Longitudinal Studies
Pre-Eclampsia - epidemiology - prevention & control
Preconception Care
Pregnancy
Proportional Hazards Models
Risk
Vitamins - administration & dosage
Abstract
The timing and frequency of periconceptional multivitamin use may be related to the risk of preeclampsia. Women in the Danish National Birth Cohort (1997-2003) reported multivitamin or folate-only supplement use during a 12-week periconceptional period (from 4 weeks prior to 8 weeks after the last menstrual period). Preeclampsia cases were identified by using International Classification of Diseases, Tenth Revision, codes. Cox regression was used to estimate the association of frequency (weeks of use) and timing (preconception and postconception) of use with preeclampsia risk. Overall, there were 668 cases of preeclampsia (2.3%), and 18,551 women (65%) reported periconceptional multivitamin use. After adjustment, regular use (12 of 12 weeks) was related to a reduced risk of preeclampsia among normal-weight women. Compared with nonusers with a body mass index of 22 kg/m(2), regular multivitamin users with the same body mass index had a 20% reduced risk of preeclampisa (hazard ratio = 0.78, 95% confidence interval: 0.60, 0.99). In addition, regular use in the postconception period only was associated with reduced risk, a relation that also appeared to be limited to women with a body mass index of
PubMed ID
19372217 View in PubMed
Less detail

192 records – page 1 of 20.